Tag: unsurance
Peter Pitts Examines the Role of PBMs and their Deceptive Tactics
A piece by Peter J. Pitts, a former FDA Associate Commissioner and President of the …
Kentucky Officials Expose PBMs for Gaming the System
While many were watching the drug pricing debate unfold on Capitol Hill, the Kentucky Cabinet …
Greenwood Shines Spotlight on Insurance Industry Rip-off
Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a …
Another Year, Another Misleading Insurance Company Report
Once again, Blue Cross Blue Shield is out with a report attempting to stoke fear …
Watchdog Report Reaffirms Concerns With Fail First
A new report by the Office of Inspector General at the U.S. Department of Health …
Hits to Patients Keep on Coming
At a time when prescription drug prices and spending are remarkably stable, patients are getting …
Report: Patients More Likely to Skip Therapy as Out-of-Pocket Costs Rise
IQVIA — a nonpartisan health care research firm — is out with troubling new data …
PBS NewsHour: Why a Patient Paid a $285 Copay for a $40 Drug
A featured story by PBS NewsHour reaffirms that insurance companies and drug cost middlemen determine …
As Out-of-Pocket Costs Rise, Insurers Spend Big on Administrative Costs
It seems every week the insurance industry is busy pointing the finger at biopharmaceutical innovators …
Insurers and PBMs Limit Access to Safer Opioid Alternatives
Opioid abuse and addiction in America continues to ravish communities, families, and individuals across the …